User:Mr. Ibrahem/Tapinarof

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Tapinarof
Clinical data
Trade namesVtama
Other namesBenvitimod; GSK-2894512; (E)-3,5-Dihydroxy-4-isopropyl-trans-stilbene; 3,5-Dihydroxy-4-isopropylstilbene
License data
Routes of
administration
Topical
Legal status
Legal status
Identifiers
  • 5-[(E)-2-Phenylethen-1-yl]-2-(propan-2-yl)benzene-1,3-diol
Chemical and physical data
FormulaC17H18O2
Molar mass254.329 g·mol−1
3D model (JSmol)
  • CC(C)c1c(cc(cc1O)/C=C/c2ccccc2)O
  • InChI=1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+
  • Key:ZISJNXNHJRQYJO-CMDGGOBGSA-N

Tapinarof, also known as benvitimod and sold under the brand name Vtama, is a medication used to treat plaque psoriasis.[1][2] It is applied to the skin.[1]

Common side effects include folliculitis, itchiness, and contact dermatitis.[1] It is an aryl hydrocarbon receptor activator.[1]

Tapinarof was approved for medical use in the United States in 2022.[1] It is not approved in either Europe or the United Kingdom as of 2022.[3] In the United States 60 grams of 1% cream costs about 1,400 USD as of 2022.[4]

References[edit]

  1. ^ a b c d e f g h "Vtama- tapinarof cream". DailyMed. 23 May 2022. Archived from the original on 3 July 2022. Retrieved 19 June 2022.
  2. ^ Stein Gold, Linda; Rubenstein, David S.; Peist, Ken; Jain, Piyush; Tallman, Anna M. (September 2021). "Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medications". Journal of the American Academy of Dermatology. 85 (3): e201–e202. doi:10.1016/j.jaad.2021.04.103.
  3. ^ "Tapinarof". SPS - Specialist Pharmacy Service. 29 August 2020. Archived from the original on 26 January 2022. Retrieved 12 December 2022.
  4. ^ "Vtama Prices, Coupons, Copay & Patient Assistance". Drugs.com. Retrieved 12 December 2022.